박용 프로필 사진

박용

Park, Yong
Scopus ORCID

자료 필터

자료유형

발행연도

2009 ~ 2029
2009 2029

키워드

언어

전체 312건 중 61번부터 70번까지의 결과를 표시합니다.

2023
Article

Phase II study of bortezomib, cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma

  • Shin, Junghoon ; 
  • Lee, Ji Yun ; 
  • Lee, Gyeong-Won ; 
  • Kim, Won Seog ; 
  • Park, Yong ; 
  • ... Kim, Dae Sik ; 
  • 외 8명
  • 2023-09
  • British Journal of Haematology
  • Blackwell Publishing Inc.
Article

A Prospective Study of Preemptive Tenofovir Disoproxil Fumarate Therapy in HBsAg-Positive Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

  • Kim, Do Young ; 
  • Kim, Yu Ri ; 
  • Suh, Cheolwon ; 
  • Yoon, Dok Hyun ; 
  • Yang, Deok-Hwan ; 
  • ... Park, Yong ; 
  • 외 17명
  • 2023-08
  • American Journal of Gastroenterology
  • Blackwell Publishing Inc.
Article

Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation

  • Kim, Seok Jin ; 
  • Jo, Jae-Cheol ; 
  • Yoon, Dok Hyun ; 
  • Yang, Deok-Hwan ; 
  • Yoon, Sang Eun ; 
  • ... Park, Yong ; 
  • ... Kang, Ka-Won ; 
  • 외 19명
  • 2023-08
  • Frontiers in Oncology
  • Frontiers Media S.A.
Conference

A randomized phase II trial of CHOP versus ICED and autologous stem cell transplantation in newly diagnosed T-cell lymphoma

  • Yoo, K H ; 
  • Kim, S J ; 
  • Jo, J ; 
  • Yoon, D H ; 
  • Yang, D ; 
  • ... Park, Y ; 
  • ... Kang, K ; 
  • 외 20명
  • 2023-06
  • 미국
Article

Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404)

  • Cho, Hyungwoo ; 
  • Yoon, Dok Hyun ; 
  • Shin, Dong-Yeop ; 
  • Koh, Youngil ; 
  • Yoon, Sung-Soo ; 
  • ... Park, Yong ; 
  • 외 19명
  • 2023-04
  • Cancer Research and Treatment
  • 대한암학회
Article

Single test-based diagnosis of multiple cancer types using Exosome-SERS-AI for early stage cancers

  • 2023-03
  • Nature Communications
  • Nature Publishing Group